Abstract:G-quadruplex (G4) motifs are noncanonical nucleic acid structures formed from staked guanine rich tetrads. G4 motifs have been shown to play significant effects on gene expression in all domains of life and are predominantly enriched in the regulatory regions such as promoters and enhancers of the human genome. G4-ligand mediated stabilization or destabilization of G4 structures has been discussed as a potential therapeutic strategy against tumor cells. However, the structure-specificity of G4-binding ligands remains a considerable challenge in determining the target-specificity. Therefore, it is necessary to understand the global effects of such G4-binding ligands at the transcriptome level to identify novel target(s) based on molecular structures and binding modes of both G4 motifs and ligands. In this study, we reported a top-down approach to extrapolate transcriptome-wide effects of two eminent G4-binding ligands Quarfloxin and Pyridostatin in human breast adenocarcinoma (MCF7) cell lines by RNA-seq analysis. Quadparser analysis was performed to analyze putative G4 forming sequences in protein coding breast cancer genes promoters. RNA-seq data was combined with Quadparser analysis to reveal that over 85% of the differentially expressed genes in both Pyridostatin and Quarfloxin contained G4 forming sequences in promoter region. Gene ontology analysis showed that both ligands affected key genes involved in extracellular matrix (ECM), architecture and cellular functions. A notable tumor suppressor deubiquitinase (DUBs) Cylindromatosis (CYLD) gene expression was particularly increased with Pyridostatin compared to Quarfloxin. In vitro assays also confirmed an increase in CYLD expression by qRT-PCR and Western blot. The detailed molecular mechanism of G4-mediated increase in CYLD expression is under study. Collectively, the current results present a new approach to identify G4-ligands binding target in breast cancer cells and provide insights into designing G4-ligands as an anti-cancer therapeutics. Citation Format: Maria Razzaq, Subramaniyam Ravichandran, Nazia Parveen, Kyeong Kyu Kim. Identification of therapeutic target in breast cancer using G-quadruplex binding ligands [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl) nr LB430.

G-Quadruplex mRNAs Silencing with Inducible Ribonuclease Targeting Chimera for Precision Tumor Therapy

Aptamer‐RIBOTAC Strategy Enabling Tumor‐Specific Targeted Degradation of MicroRNA for Precise Cancer Therapy

In vitro cleavage of mdrl mrna fragment by synthetic ribozyme (rz) and transcribed ribozyme from tna-trimming plasmid

G‐Quadruplex‐Programmed Versatile Nanorobot Combined with Chemotherapy and Gene Therapy for Synergistic Targeted Therapy

G-quadruplex-guided RNA Engineering to Modulate CRISPR-based Genomic Regulation

Biomimetic RNA-silencing Nanocomplexes: Overcoming Multidrug Resistance in Cancer Cells.

Boosting RNAi Therapy for Orthotopic Glioblastoma with Nontoxic Brain-Targeting Chimaeric Polymersomes

Discovery of A G‐Quadruplex Unwinder That Unleashes the Translation of G‐Quadruplex‐Containing mRNA without Inducing DNA Damage

Targeted Inhibition of Oncogenic Mir-21 Maturation with Designed RNA-binding Proteins.

Abstract LB430: Identification of therapeutic target in breast cancer using G-quadruplex binding ligands

Regulated induced proximity targeting chimeras-RIPTACs-A heterobifunctional small molecule strategy for cancer selective therapies

A General Approach to High-Yield Biosynthesis of Chimeric Rnas Bearing Various Types of Functional Small Rnas for Broad Applications

Robust G-Quadruplex Dimer-Guided Transmembrane DNA Nanovehicles for Targeted Payload Delivery

Ribozyme-Spherical Nucleic Acids.

Cell‐Specific Control of Mammalian Gene Expression Using DNA Repair Inducible Ribozyme Switches

Bioengineering Novel Chimeric Microrna-34A for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization.

Polymorphic and Higher-Order G-Quadruplexes as Possible Transcription Regulators: Novel Perspectives for Future Anticancer Therapeutic Applications

Regulation and Imaging of Gene Expression Via an RNA Interference Antagonistic Biomimetic Probe

Enhanced Target Gene Knockdown by a Bifunctional Shrna: a Novel Approach of RNA Interference

Virus-Mimicking Chimaeric Polymersomes Boost Targeted Cancer Sirna Therapy in Vivo.

G‐quadruplex RNA Based PROTAC Enables Targeted Degradation of RNA Binding Protein FMRP for Tumor Immunotherapy